CRISPR Therapeutics AG (CRSP) Other Working Capital Changes (2015 - 2026)

CRISPR Therapeutics AG has disclosed Other Working Capital Changes across 12 years of filings, most recently posting $841000.0 for Q2 2026.

• In Q2 2026, Other Working Capital Changes rose 804.3% year-over-year to $841000.0; the TTM figure through Jun 2026 stood at -$3.0 million (down 502.71% YoY), while the FY2025 annual figure was -$3.3 million, up 36.86% from the prior year.
• Other Working Capital Changes came in at $841000.0 for Q2 2026 at CRISPR Therapeutics AG, up from $247000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $7.0 million in Q3 2023 to a low of -$1.2 million in Q4 2023.
• Average Other Working Capital Changes over 5 years is $115937.5, with a median of -$465500.0 recorded in 2024.
• Year-over-year, Other Working Capital Changes slumped 2088.64% in 2025 and jumped 804.3% in 2026.
• Over 5 years, Other Working Capital Changes stood at $5.5 million in 2022, then tumbled by 218.05% to -$6.4 million in 2023, then soared by 97.27% to -$176000.0 in 2024, then tumbled by 2088.64% to -$3.9 million in 2025, then jumped by 121.83% to $841000.0 in 2026.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were $841000.0 in Q2 2026, $247000.0 in Q1 2026, and -$3.9 million in Q4 2025.